[1]Fernandez U I, Hammer K, Arndt M A, et al. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity[J]. Int J Cancer, 2014, 136(9): 2228-2240.
[2]Chen X J, Zhang K, Xin Y, et al. Oncolytic adenovirusexpressed RNA interference of Omethylguanine DNA methyltransferase activity may enhance the antitumor effects of temozolomide[J]. Oncol Lett, 2014, 8(5): 2201-2202.
[3] Kirn D, NiculescuDuvaz I, Hallden G, et al. The emerging fields of suicide gene therapy and virotherapy[J]. Trends Mol Med, 2002, 8(S4): 68-73.
[4] Kirn D. Replicationselective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer[J]. Oncogene, 2000, 19(56): 6660-6669.
[5] Bravard A, Sabatier L, Hoffschir F, et al. SOD2: a new type of tumorsuppressor gene?[J]. Int J Cancer, 1992, 51(3): 476-480.
[6] Zhang Y H, Gu J F, Zhao L L. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factorrelated apoptosisinducing ligand gene virotherapy[J]. Cancer Res, 2006, 66(8): 4291-4298.
[7] Kinnula V L, Crapo, J D. Superoxide dismutases in the lung and human lung diseases[J]. Am J Respir Crit Care Med, 2003, 167(12): 1600-1619.
[8] Oberley T D, Zhong W, Szweda L I, et al. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium[J]. Prostate, 2000, 44(2): 144-155.
[9] Hur G C, Cho S J, Kim C H, et al. Manganese superoxide dismutase expression correlates with chemosensitivity in human gastric Cancer Cell lines[J]. Clinical Cancer Research, 2003, 9(15): 5768-5775.
[10]Hwang T S, Choi H K, Han H S. Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa[J]. Eur J Surg Oncol, 2007, 33(4): 474-479.
[11] Misra R N, Xiao H Y, Kim K S, et al. N(cycloalkylamino)acyl2aminothiazole inhibitors of cyclindependentkinase2N[5[[[5(1, 1dimethylethyl)2oxazolyl]methyl]thio]2thiazolyl]4piperidinecarboxamide(BMS387032), a highly efficacious and selective antitumor agent[J]. J Med Chem, 2004, 47(7): 1719-1728.
[12] Mukhopadhyay P, Ali M A, Nandi A, et al. The cyclindependent kinase 2 inhibitor downregulates interleukin1betamediated induction of cyclooxygenase2 expression in human lung carcinoma cells[J]. Cancer Res, 2006, 66(3): 1758-1766.
[1]谢国良,肖连立,李新,等.GSK-3抑制剂增强携带TRAIL的溶瘤腺病毒对肝癌细胞的杀伤作用[J].浙江理工大学学报,2011,28(02):235.
[2]冯志华,苏长青,钱其军,等.携带11R穿膜肽-p53融合蛋白基因的溶瘤腺病毒的抗肿瘤作用[J].浙江理工大学学报,2011,28(02):256.
[3]杨耿兵,何倩,黄青红,等. 双靶向溶瘤腺病毒联合奥沙利铂对肿瘤细胞凋亡的研究[J].浙江理工大学学报,2011,28(05):795.
YANG Geng bing,HE Qian,HUANG Qing hong,et al. Study on Apoptosis of Tumor Cells Treated by DualTargeting Replicated Adenovirus Combined with Oxaliplatin[J].Journal of Zhejiang Sci-Tech University,2011,28(自科5):795.